News Item

  • May 16, 2022
  • Healio.com

Remote patient monitoring using novel technology may make it possible for rheumatologists to choose the “right drug right out of...

News Item

  • February 9, 2022

Originally published by Andrea Park – 02/01/2022 – Source URL Equipped with a blood test capable of predicting an individual’s...

News Item

  • February 9, 2022

PrismRA, a first of its kind molecular signature test, predicts non-response to TNFi therapies in patients with rheumatoid arthritis (RA)...

News Item

  • Press Release
  • October 12, 2021

October 12, 2021, Atlanta, GA and Waltham, MA – Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the...

News Item

  • Press Release
  • September 16, 2021

SEPTEMBER 16, 2021 – WALTHAM, MA Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced...

News Item

  • Article
  • August 30, 2021

Author: Bret Stetka, MD Results from a new study suggest that a simple blood test can identify patients who are...

News Item

  • Article
  • August 19, 2021

Specialty drug spending contributes the largest share to rising healthcare costs. To make matters worse, in the case of rheumatoid...

News Item

  • Article
  • August 17, 2021

Richard Mark Kirkner via Medscape A blood test that uses a patient’s unique genetic signature has shown some ability to...

News Item

  • Article
  • August 16, 2021

Q&A with Erin Connolly-Strong PhD, Head Medical Affairs Scipher Medicine via BiopharmaDive Multiple classes of drugs exist for treating rheumatoid...

News Item

  • Press Release
  • July 29, 2021

Expanded intended use for the blood test validated in Network-004 study. Now, most rheumatoid arthritis patients can be tested at...